本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

传奇生物

29.72
-0.5700-1.88%
盘后29.720.00000.00%16:10 EST
成交量:130.54万
成交额:3,921.50万
市值:54.85亿
市盈率:-22.82
高:30.55
开:30.05
低:29.71
收:30.29
52周最高:45.30
52周最低:27.34
股本:1.85亿
流通股本:8,138.20万
量比:0.66
换手率:1.60%
股息:- -
股息率:- -
每股收益(TTM):-1.3026
每股收益(LYR):-0.9681
净资产收益率:-22.53%
总资产收益率:-6.92%
市净率:5.42
市盈率(LYR):-30.70

数据加载中...

2024/12/26

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/12/02

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/11/14

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2024/09/25

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/09/20

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/09/20

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/09/12

SEC问询函

Form CORRESP - Correspondence
2024/06/25

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/06/25

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/03/29

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/03/28

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/03/27

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/03/26

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/03/26

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/03/19

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/03/19

年度报告

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2024/02/29

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/02/28

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/02/23

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/02/14

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]